CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-22 | Keyes Jason A Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −70,000 | 0 | ||
| 2020-04-22 | Keyes Jason A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2020-04-22 | Keyes Jason A Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −90,000 | 0 | ||
| 2020-04-22 | Keyes Jason A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2020-04-22 | Polu Krishna R Chief Medical Officer | Returned to the company · Stock Option (right to buy) | −208,216 | 0 | ||
| 2020-04-22 | Polu Krishna R Chief Medical Officer | Grant or award · Stock Option (right to buy) | +208,216 | 208,216 | ||
| 2020-04-22 | Polu Krishna R Chief Medical Officer | Returned to the company · Stock Option (right to buy) | −90,000 | 0 | ||
| 2020-04-22 | Polu Krishna R Chief Medical Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2020-04-22 | Polu Krishna R Chief Medical Officer | Returned to the company · Stock Option (right to buy) | −125,000 | 0 | ||
| 2020-04-22 | Polu Krishna R Chief Medical Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2020-04-22 | Zedelmayer Christine Sr. Vice President and COO | Returned to the company · Stock Option (right to buy) | −35,695 | 0 | ||
| 2020-04-22 | Zedelmayer Christine Sr. Vice President and COO | Grant or award · Stock Option (right to buy) | +35,695 | 35,695 | ||
| 2020-04-22 | Zedelmayer Christine Sr. Vice President and COO | Returned to the company · Stock Option (right to buy) | −50,000 | 0 | ||
| 2020-04-22 | Zedelmayer Christine Sr. Vice President and COO | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-04-22 | Zedelmayer Christine Sr. Vice President and COO | Returned to the company · Stock Option (right to buy) | −90,000 | 0 | ||
| 2020-04-22 | Zedelmayer Christine Sr. Vice President and COO | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2020-02-18 | Keyes Jason A Chief Financial Officer | Sale | −5,000 | $5.03 | $25K | 130,520 |
| 2020-01-21 | Keyes Jason A Chief Financial Officer | Sale | −5,000 | $4.41 | $22K | 135,520 |
| 2019-12-10 | Steel Bruce D. President, CBO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-12-10 | BRADBURY DANIEL Chief Executive Officer | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 |
Page 16 of 17 · 339 trades